{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T22:01:02Z","timestamp":1775253662387,"version":"3.50.1"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T00:00:00Z","timestamp":1519344000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00237","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T04:26:49Z","timestamp":1519360009000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Herpesviruses in the Activated Phosphatidylinositol-3-Kinase-\u03b4 Syndrome"],"prefix":"10.3389","volume":"9","author":[{"given":"Jeffrey I.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,2,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K pathway in human disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.virol.2015.02.040","article-title":"The role of PI3K\/Akt in human herpesvirus infection: from the bench to the bedside","author":"Liu","year":"2015","journal-title":"Virology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.3390\/v5123192","article-title":"Make yourself at home: viral hijacking of the PI3K\/Akt signaling pathway","volume":"5","author":"Diehl","year":"2013","journal-title":"Viruses"},{"key":"B4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/B978-0-12-396456-4.00002-X","article-title":"HijAkt: the PI3K\/Akt pathway in virus replication and pathogenesis","volume":"106","author":"Dunn","year":"2012","journal-title":"Prog Mol Biol Transl Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e9560","DOI":"10.1371\/journal.pone.0009560","article-title":"Binding of herpes simplex virus type-1 virions leads to the induction of intracellular signalling in the absence of virus entry","volume":"5","author":"MacLeod","year":"2010","journal-title":"PLoS One"},{"key":"B6","doi-asserted-by":"publisher","first-page":"6022","DOI":"10.1128\/JVI.75.13.6022-6032.2001","article-title":"Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling","volume":"75","author":"Johnson","year":"2001","journal-title":"J Virol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1002\/eji.200324059","article-title":"Activation of Epstein\u2013Barr virus\/C3d receptor (gp140, CR2, CD21) on human cell surface triggers pp60src and Akt\u2013GSK3 activities upstream and downstream to PI 3-kinase, respectively","volume":"33","author":"Barel","year":"2003","journal-title":"Eur J Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1128\/JVI.77.2.1524-1539.2003","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase\u2013PKC-zeta\u2013MEK\u2013ERK signaling pathway in target cells early during infection: implications for infectivity","volume":"77","author":"Naranatt","year":"2003","journal-title":"J Virol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1096\/fj.12-220285","article-title":"HSV activates Akt to trigger calcium release and promote viral entry: novel candidate target for treatment and suppression","volume":"27","author":"Cheshenko","year":"2013","journal-title":"FASEB J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.18632\/oncotarget.1787","article-title":"HCMV glycoprotein B is expressed in primary glioblastomas and enhances growth and invasiveness via PDGFR-alpha activation","volume":"5","author":"Cobbs","year":"2014","journal-title":"Oncotarget"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.1128\/JVI.78.8.4207-4223.2004","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus\/human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent focal adhesion kinase\u2013Src\u2013phosphatidylinositol 3-kinase\u2013rho GTPase signal pathways and cytoskeletal rearrangements","volume":"78","author":"Sharma-Walia","year":"2004","journal-title":"J Virol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1471-4159.2009.06475.x","article-title":"Multi-targeted neuroprotection by the HSV-2 gene ICP10PK includes robust bystander activity through PI3-K\/Akt and\/or MEK\/ERK-dependent neuronal release of vascular endothelial growth factor and fractalkine","volume":"112","author":"Laing","year":"2010","journal-title":"J Neurochem"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1128\/JVI.02395-12","article-title":"Varicella\u2013zoster virus ORF12 protein activates the phosphatidylinositol 3-kinase\/Akt pathway to regulate cell cycle progression","volume":"87","author":"Liu","year":"2013","journal-title":"J Virol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1128\/JVI.76.8.3731-3738.2002","article-title":"Human cytomegalovirus major immediate-early proteins and simian virus 40 large T antigen can inhibit apoptosis through activation of the phosphatidylinositide 3'-OH kinase pathway and the cellular kinase Akt","volume":"76","author":"Yu","year":"2002","journal-title":"J Virol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"6135","DOI":"10.1128\/JVI.75.13.6135-6142.2001","article-title":"Epstein\u2013Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation","volume":"75","author":"Darr","year":"2001","journal-title":"J Virol"},{"key":"B16","first-page":"2641","article-title":"The Kaposi\u2019s sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt\/protein kinase B","volume":"61","author":"Montaner","year":"2001","journal-title":"Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"6668","DOI":"10.1128\/JVI.06240-11","article-title":"Cdk1 inhibition induces mutually inhibitory apoptosis and reactivation of Kaposi\u2019s sarcoma-associated herpesvirus","volume":"86","author":"Li","year":"2012","journal-title":"J Virol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.chom.2010.09.007","article-title":"Nature and duration of growth factor signaling through receptor tyrosine kinases regulates HSV-1 latency in neurons","volume":"8","author":"Camarena","year":"2010","journal-title":"Cell Host Microbe"},{"key":"B19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0898-6568(02)00083-9","article-title":"CD40 and its viral mimic, LMP1: similar means to different ends","volume":"15","author":"Lam","year":"2003","journal-title":"Cell Signal"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1038\/oncsis.2012.5","article-title":"COX-2\/PGE2: molecular ambassadors of Kaposi\u2019s sarcoma-associated herpes virus oncoprotein-v-FLIP","volume":"1","author":"Sharma-Walia","year":"2012","journal-title":"Oncogenesis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1099\/vir.0.015719-0","article-title":"Herpes simplex virus type 1 latency-associated transcript inhibits apoptosis and promotes neurite sprouting in neuroblastoma cells following serum starvation by maintaining protein kinase B (Akt) levels","volume":"91","author":"Li","year":"2010","journal-title":"J Gen Virol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.1074\/jbc.M209840200","article-title":"Epstein\u2013Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase\/Akt pathway to promote cell survival and induce actin filament remodeling","volume":"278","author":"Dawson","year":"2003","journal-title":"J Biol Chem"},{"key":"B23","doi-asserted-by":"publisher","first-page":"9299","DOI":"10.1128\/JVI.00537-07","article-title":"Epstein\u2013Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras\/PI3-K\/Akt pathway","volume":"81","author":"Fukuda","year":"2007","journal-title":"J Virol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1099\/vir.0.82128-0","article-title":"Cell target genes of Epstein\u2013Barr virus transcription factor EBNA-2: induction of the p55alpha regulatory subunit of PI3-kinase and its role in survival of EREB2.5 cells","volume":"87","author":"Spender","year":"2006","journal-title":"J Gen Virol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.antiviral.2012.09.021","article-title":"Protein kinase inhibitors that inhibit induction of lytic program and replication of Epstein\u2013Barr virus","volume":"96","author":"Goswami","year":"2012","journal-title":"Antiviral Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1099\/vir.0.015073-0","article-title":"Inhibition of the phosphatidylinositol 3-kinase\u2013Akt pathway enhances gamma-2 herpesvirus lytic replication and facilitates reactivation from latency","volume":"91","author":"Peng","year":"2010","journal-title":"J Gen Virol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1128\/JVI.01877-10","article-title":"Herpes simplex virus requires VP11\/12 to activate Src family kinase phosphoinositide 3-kinase\u2013Akt signaling","volume":"85","author":"Wagner","year":"2011","journal-title":"J Virol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"12173","DOI":"10.1128\/JVI.79.19.12173-12184.2005","article-title":"Characterization of the Kaposi\u2019s sarcoma-associated herpesvirus K1 signalosome","volume":"79","author":"Lee","year":"2005","journal-title":"J Virol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1126\/science.1243292","article-title":"Phosphoinositide 3-kinase \u03b4 gene mutation predisposes to respiratory infection and airway damage","volume":"342","author":"Angulo","year":"2013","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ni.2771","article-title":"Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110\u03b4 result in T cell senescence and human immunodeficiency","volume":"15","author":"Lucas","year":"2014","journal-title":"Nat Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1172\/JCI75746","article-title":"A human immunodeficiency caused by mutations in the PIK3R1 gene","volume":"124","author":"Deau","year":"2014","journal-title":"J Clin Invest"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1084\/jem.20141759","article-title":"Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K","volume":"211","author":"Lucas","year":"2014","journal-title":"J Exp Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1084\/jem.20112533","article-title":"Agammaglobulinemia and absent B lineage cells in a patient lacking the p85\u03b1 subunit of PI3K","volume":"209","author":"Conley","year":"2012","journal-title":"J Exp Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s10875-014-0012-9","article-title":"Mutations in PIK3CD can cause hyper IgM syndrome (HIGM) associated with increased cancer susceptibility","volume":"34","author":"Crank","year":"2014","journal-title":"J Clin Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10875-014-0109-1","article-title":"Gain of function mutations of PIK3CD as a cause of primary sclerosing cholangitis","volume":"35","author":"Hartman","year":"2015","journal-title":"J Clin Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.anai.2015.08.009","article-title":"Activated phosphoinositide 3-kinase \u03b4 syndrome in a patient with a former diagnosis of common variable immune deficiency, bronchiectasis, and lymphoproliferative disease","volume":"115","author":"Kannan","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"461.e","DOI":"10.1016\/j.jaip.2014.10.017","article-title":"6-year-old boy with recurrent sinopulmonary infections and lymphadenopathy","volume":"3","author":"Lawrence","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/cei.12706","article-title":"Activating PI3K\u03b4 mutations in a cohort of 669 patients with primary immunodeficiency","volume":"183","author":"Elgizouli","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jaci.2016.08.028","article-title":"Abnormal B-cell maturation in the bone marrow of patients with germline mutations in PIK3CD","volume":"139","author":"Dulau Florea","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","article-title":"Clinical spectrum and features of activated phosphoinositide 3-kinase \u03b4 syndrome: a large patient cohort study","volume":"139","author":"Coulter","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.imlet.2017.08.021","article-title":"Early diagnosis of PI3K\u03b4 syndrome in a 2 years old girl with recurrent otitis and enlarged spleen","volume":"190","author":"Saettini","year":"2017","journal-title":"Immunol Lett"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1152.e10","DOI":"10.1016\/j.jaci.2017.03.026","article-title":"Novel PIK3CD mutations affecting N-terminal residues of p110\u03b4 cause activated PI3K\u03b4 syndrome (APDS) in humans","volume":"140","author":"Takeda","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.clim.2015.12.008","article-title":"The case of an APDS patient: defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment","volume":"178","author":"Chiriaco","year":"2017","journal-title":"Clin Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10875-017-0393-7","article-title":"Persistent impairment of T-cell regeneration in a patient with activated PI3K \u03b4 syndrome","volume":"37","author":"Goto","year":"2017","journal-title":"J Clin Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"210.e","DOI":"10.1016\/j.jaci.2016.03.022","article-title":"Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase \u03b4 syndrome 2: a cohort study","volume":"138","author":"Elkaim","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/pai.12585","article-title":"Activated PI3K\u03b4 syndrome type 2: two patients, a novel mutation, and review of the literature","volume":"27","author":"Olbrich","year":"2016","journal-title":"Pediatr Allergy Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.clim.2015.10.008","article-title":"De novo PIK3R1 gain-of-function with recurrent sinopulmonary infections, long-lasting chronic CMV-lymphadenitis and microcephaly","volume":"162","author":"Kuhlen","year":"2016","journal-title":"Clin Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.clim.2017.03.004","article-title":"Mutations in PIK3R1 can lead to APDS2, SHORT syndrome or a combination of the two","volume":"179","author":"Bravo Garc\u00eda-Morato","year":"2017","journal-title":"Clin Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1055\/s-0043-104218","article-title":"Variant PIK3R1 hypermorphic mutation and clinical phenotypes in a family with short statures, mild immunodeficiency and lymphoma","volume":"229","author":"Hauck","year":"2017","journal-title":"Klin Padiatr"},{"key":"B50","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1471-2318-14-50","article-title":"Immunosenescence in the nursing home elderly","volume":"17","author":"Johnstone","year":"2014","journal-title":"BMC Geriatr"},{"key":"B51","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0531-5565(01)00212-1","article-title":"Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study","volume":"37","author":"Wikby","year":"2002","journal-title":"Exp Gerontol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e0180841","DOI":"10.1371\/journal.pone.0180841","article-title":"Aged-associated cytomegalovirus and Epstein\u2013Barr virus reactivation and cytomegalovirus relationship with the frailty syndrome in older women","volume":"12","author":"Thomasini","year":"2017","journal-title":"PLoS One"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12979-015-0056-6","article-title":"Cytomegalovirus viral load within blood increases markedly in healthy people over the age of 70 years","volume":"13","author":"Parry","year":"2016","journal-title":"Immun Ageing"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1182\/blood-2008-06-164806","article-title":"Age-related Epstein\u2013Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients","volume":"113","author":"Asano","year":"2009","journal-title":"Blood"},{"key":"B55","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.immuni.2012.09.020","article-title":"Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets","volume":"38","author":"Sathaliyawala","year":"2013","journal-title":"Immunity"},{"key":"B56","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nri3567","article-title":"Human memory T cells: generation, compartmentalization and homeostasis","volume":"14","author":"Farber","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1182\/blood-2017-08-801191","article-title":"Effective \u2018activated PI3K\u03b4 syndrome\u2019-targeted therapy with the PI3K\u03b4 inhibitor leniolisib","volume":"130","author":"Rao","year":"2017","journal-title":"Blood"},{"key":"B58","first-page":"4472","article-title":"Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein\u2013Barr virus B-cell lymphomas","volume":"63","author":"Nepomuceno","year":"2003","journal-title":"Cancer Res"},{"key":"B59","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/j.1432-2277.2008.00655.x","article-title":"Inhibition of mTOR by sirolimus induces remission of post-transplant lymphoproliferative disorders","volume":"21","author":"Boratynska","year":"2008","journal-title":"Transpl Int"},{"key":"B60","doi-asserted-by":"publisher","first-page":"11030","DOI":"10.1128\/JVI.78.20.11030-11039.2004","article-title":"Human cytomegalovirus infection induces rapamycin-insensitive phosphorylation of downstream effectors of mTOR kinase","volume":"78","author":"Kudchodkar","year":"2004","journal-title":"J Virol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1097\/TP.0b013e31824810e6","article-title":"Review of cytomegalovirus infection findings with mammalian target of rapamycin inhibitor-based immunosuppressive therapy in de novo renal transplant recipients","volume":"93","author":"Nashan","year":"2012","journal-title":"Transplantation"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00237\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T04:26:54Z","timestamp":1519360014000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00237\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,23]]},"references-count":61,"alternative-id":["10.3389\/fimmu.2018.00237"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00237","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,23]]},"article-number":"237"}}